Event Videos

HEPATICON 2020 : ALL ABOUT JAUNDICE


Videos of Hepaticon 2020: Click here


Hepaticon 2020 was organised on 2nd Feb, 2020 by Children's Liver foundation and IAP, Mumbai and was endorsed by ISPGHAN (Indian Society of Pediatric Gastroenterology Hepatology and Nutrition). It was held at Nehru Centre, Mumbai. Hepaticons have been regularly organised for the last 5 years and have been popular for their case based discussions and interactive format. The theme this year was "All about Jaundice"
 
Dr Aabha Nagral, the organising secretary of Hepaticon 2020 introduced the intercollegiate PG quiz for the first time with 23 teaching institutions from Mumbai and Pune participating in the quiz. It was a huge success with a theory MCQ round in the beginning followed by selection of the 5 top teams and an oral round in the main meeting. It was conducted by Dr John Matthai who kept the packed house completely spellbound throughout upto an exciting finish. Jagjivan Ram Hospital, Wadia Hospital and Sion Hospital teams got the first, second and third prizes respectively.
 
The inauguration included a short film on the activities of Children's Liver Foundation by Dr Aabha Nagral  and talks by IAP, Mumbai President Vinay Joshi, IAP Mumbai past president Uday Pai and Dr John Matthai , President ISPGHAN and Dr YK Amdekar who is passionate about teaching and has been regularly involved in all the Hepaticons. 
 
The interactive case discussions were on all common situations which can cause jaundice in clinical practice and cases ranging from neonatal jaundice to acute liver failure were presented by Pediatrics PGs and Pediatric Gastroenterology PGs from Mumbai and outside.
 
The National faculty included Dr SK Yachha (Bangalore), Dr John Matthai (Coimbatore), Dr Malathi Satiyasekaran (Chennai), Dr Anshu Srivastava (Lucknow), Dr Ashish Bavdekar (Pune), Dr Seema Alam (Delhi), Dr Lalit Bharadia (Jaipur) and Dr Yogesh Waikar (Nagpur) and Dr Girish Gupte from Birmingham,UK.
 
The national and local faculty from Mumbai participated not only in their sessions but actively contributed throughout the meeting. The meeting was webcast and has been accessed by a large number of Pediatricians all over the country. The live telecast of the  meeting will soon be available on this website.

Watch live proceedings of Hepaticon 2020

PreviewAttachmentSize
hepaticon_2020_final_program_jpg.jpg236.13 KB
Hepaticon2020_final_program.pdf1.78 MB
hepaticon2020.jpeg217.75 KB
Read more

Community Socioeconomic Deprivation and Non-Alcoholic Fatty Liver Disease Severity.

https://www.ncbi.nlm.nih.gov/pubmed/31651666 NAFLD

J Pediatr Gastroenterol Nutr. 2019 Oct 22. doi: 10.1097/MPG.0000000000002527. [Epub ahead of print]
Community Socioeconomic Deprivation and Non-Alcoholic Fatty Liver Disease Severity.
Orkin S1, Brokamp C2,3, Yodoshi T1, Trout AT4,3,5, Liu C2, Meryum S1, Taylor S6, Wolfe C2, Sheridan R7, Seth A8, Bhuiyan MAN2, Ley S9,3, Arce-Clachar AC1,3, Bramlage K1, Kahn R10, Xanthakos S1,3, Beck AF6,3,10,11, Mouzaki M1,3.

Abstract

BACKGROUND AND OBJECTIVES:

Published on: 
Oct-2019
Read more

Ten-year follow-up of children with hydatid cysts

https://www.ncbi.nlm.nih.gov/pubmed/31619929 Hydatid cyst
Turk Pediatri Ars. 2019 Sep 25;54(3):173-178. doi: 10.14744/TurkPediatriArs.2019.24119. eCollection 2019.
Ten-year follow-up of children with hydatid cysts.
Eyüboğlu TŞ1, Gürsoy TR2, Aslan AT2, Pekcan S3, Budakoğlu Iİ4.
Abstract
in English, Turkish

AIM:
Hydatid cystic disease is an endemic parasitic disease that is common in the world. We aimed to review the demographic, clinical and laboratory findings, and treatments and outcomes of children with hydatid cyst disease, and to determine the factors affecting treatment response in two pediatric pulmonology centers in the central region of Turkey.

MATERIAL AND METHODS:

Published on: 
Oct-2019
Read more

Childhood Obesity: A Risk Factor for Non-alcoholic Fatty Liver Disease in Adolescence.

https://www.ncbi.nlm.nih.gov/pubmed/31651803 NAFLD
J Pediatr Gastroenterol Nutr. 2019 Oct 23. doi: 10.1097/MPG.0000000000002523. [Epub ahead of print]
Childhood Obesity: A Risk Factor for Non-alcoholic Fatty Liver Disease in Adolescence.
Benítez VC1, Alberti G1, Uauy R1,2, Pereira A2, García C1, de Barbieri F1, Corvalán C2, Santos JL1, Mericq V3, Villarroel L1, Gana JC1.

Abstract
Non-alcoholic fatty liver disease (NAFLD), defined as fat accumulation >5% in hepatocytes, may progress to fibrosis or cirrhosis later in life. NAFLD prevalence in adolescents has increased significantly in direct relation with obesity prevalence. Fatty liver has become the most frequent indication for liver transplantation in adults.

OBJECTIVE:

Published on: 
Oct-2019
Read more

Hepatitis A Virus-related Pediatric Liver Disease Burden and its Significance in the Indian Subcontinent.

https://www.ncbi.nlm.nih.gov/pubmed/31638005 Hepatitis A
Indian Pediatr. 2019 Sep 15;56(9):741-744.
Hepatitis A Virus-related Pediatric Liver Disease Burden and its Significance in the Indian Subcontinent.
Sood V1, Lal BB1, Gupta E2, Khanna R1, Siloliya MK1, Alam S3.

Abstract

OBJECTIVE:
To study the Hepatitis A virus (HAV) infection-related pediatric liver disease burden.

METHODS:
Hospital records of 431 children (age <18 y) diagnosed to be suffering from acute HAV infection during 2011 to 2018 were extracted and analyzed. Additionally, a seroprevalence study was done on 2599 participants (696 children and 1903 adults).

RESULTS:

Published on: 
Oct-2019
Read more

β-Klotho gene variation is associated with liver damage in children with NAFLD

https://www.ncbi.nlm.nih.gov/pubmed/31652022 Transplant
Pediatr Transplant. 2019 Oct 25:e13608. doi: 10.1111/petr.13608. [Epub ahead of print]
The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.
Fuhrman DY1,2,3, Kellum JA2, Joyce EL2,3, Miyashita Y3, Mazariegos GV4, Ganoza A4, Squires JE5.

Abstract

BACKGROUND:
AKI after pediatric liver transplantation is associated with increased morbidity and mortality. The role of urinary biomarkers for the prediction of AKI in pediatric patients after liver transplantation has not been previously reported. The primary objective of this prospective pilot study was to determine the predictive capabilities of urinary KIM-1, NGAL, TIMP-2, and IGFBP7 for diagnosing AKI.

METHODS:

Published on: 
Oct-2019
Read more

Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China

https://www.ncbi.nlm.nih.gov/pubmed/31646984 Thalessemia
BMC Pediatr. 2019 Oct 23;19(1):375. doi: 10.1186/s12887-019-1744-8.
Evaluation of the vitamin D and biomedical statuses of young children with β-thalassemia major at a single center in southern China.
Yu U1, Chen L1, Wang X1, Zhang X1, Li Y1, Wen F1, Liu S2.

Abstract

BACKGROUND:
In young children, β-thalassemia major (β-TM) is associated with potentially severe clinical characteristics, including poor growth, feeding difficulties, hepatosplenomegaly, bone metabolic disorders, and skeletal abnormalities.

METHODS:

Published on: 
Oct-2019
Read more

β-Klotho gene variation is associated with liver damage in children with NAFLD

https://www.ncbi.nlm.nih.gov/pubmed/31655133 NAFLD
J Hepatol. 2019 Oct 23. pii: S0168-8278(19)30613-0. doi: 10.1016/j.jhep.2019.10.011.
β-Klotho gene variation is associated with liver damage in children with NAFLD.
Dongiovanni P1, Crudele A2, Panera N3, Romito I4, Meroni M5, De Stefanis C6, Palma A7, Comparcola D8, Fracanzani AL9, Miele L10, Valenti L11, Nobili V12, Alisi A13.

Abstract

BACKGROUND AND AIM:

Published on: 
Oct-2019
Read more

Efficacy And Safety Of Sodium Benzoate In The Management Of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood- A Double Blind Randomised Controlled Trial

https://www.ncbi.nlm.nih.gov/pubmed/31651665 Chronic liver disease
J Pediatr Gastroenterol Nutr. 2019 Oct 22. doi: 10.1097/MPG.0000000000002521. [Epub ahead of print]
Efficacy And Safety Of Sodium Benzoate In The Management Of Hyperammonemia in Decompensated Chronic Liver Disease of the Childhood- A Double Blind Randomised Controlled Trial.
Snehavardhan P1, Lal BB, Sood V, Khanna R, Alam S.

Abstract

OBJECTIVE:
The objective was to evaluate the efficacy and safety of sodium benzoate in the management of hyperammonemia and hepatic encephalopathy in decompensated chronic liver disease (CLD).

METHODS:

Published on: 
Oct-2019
Read more

Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease

https://www.ncbi.nlm.nih.gov/pubmed/31657145 NAFLD
Pediatr Obes. 2019 Oct 27. doi: 10.1111/ijpo.12581. [Epub ahead of print]
Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.
Seth A1, Orkin S2, Yodoshi T2, Liu C3, Fei L3, Hardy J2, Trout AT4, Arce Clachar AC2, Bramlage K2, Xanthakos S2, Mouzaki M2.

Abstract

BACKGROUND:

Paediatric non-alcoholic fatty liver disease (NAFLD) is highly prevalent among children with obesity. The primary objective of this study was determining whether obesity severity is associated with NAFLD severity. By using paediatric classifications for severe obesity, clinicians may be able to better risk stratify patients, which in turn would guide more effective management and treatment.

METHODS:

Published on: 
Oct-2019
Read more
« first ‹ previous … 77 78 79 80 81 82 83 84 85 … next › last »

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: